Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2024-10-042024-10-042020-07-31https://hdl.handle.net/11288/597703enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/InterferonInterferon for COVID-19Clinical evidenceTreatment guidelinesImmune systemCytokinesTreatment for COVID-19 patientsType 1 InterferonHuman cellsBiologyInterferon for COVID-19: Evidence review of the clinical benefit and harmTechnical Report